Search Results - Hays, D.M

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    Progress in the surgical management of vaginal rhabdomyosarcoma: A 25-year review from the Intergroup Rhabdomyosarcoma Study Group

    Progress in the surgical management of vaginal rhabdomyosarcoma: A 25-year review from the Intergroup Rhabdomyosarcoma Study Group by Andrassy, R.J., Wiener, E.S., Raney, R.B., Hays, D.M., Arndt, C.A.S., Lobe, T.E., Lawrence, W., Anderson, J.R., Qualman, S.J., Crist, W.M.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Low volume spring developments

    Low volume spring developments by Northup, B.K, Goerend, D.T, Hays, D.M, Nicholson, R.A

    Published in Rangelands
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Improved physiologically based pharmacokinetic model for oral exposures to chromium in mice, rats, and humans to address temporal variation and sensitive populations

    Improved physiologically based pharmacokinetic model for oral exposures to chromium in mice, rats, and humans to address temporal variation and sensitive populations by Kirman, C.R., Suh, M., Proctor, D.M., Hays, S.M.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Physiologically based pharmacokinetic model for rats and mice orally exposed to chromium

    Physiologically based pharmacokinetic model for rats and mice orally exposed to chromium by Kirman, C.R., Hays, S.M., Aylward, L.L., Suh, M., Harris, M.A., Thompson, C.M., Haws, L.C., Proctor, D.M.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    A phase Ib/II and pharmacokinetic study of EP0057 (formerly CRLX101) in combination with weekly paclitaxel in patients with recurrent or persistent epithelial ovarian, fallopian tube, or primary peritoneal cancer

    A phase Ib/II and pharmacokinetic study of EP0057 (formerly CRLX101) in combination with weekly paclitaxel in patients with recurrent or persistent epithelial ovarian, fallopian tu... by Duska, L.R., Krasner, C.N., O'Malley, D.M., Hays, J.L., Modesitt, S.C., Mathews, C.A., Moore, K.N., Thaker, P.H., Miller, A., Purdy, C., Zamboni, W.C., Lucas, A.T., Supko, J.G., Schilder, R.J.

    Published in Gynecologic oncology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Unexpected mechanisms of resistance in Dutch Pseudomonas aeruginosa isolates collected during 14 years of surveillance

    Unexpected mechanisms of resistance in Dutch Pseudomonas aeruginosa isolates collected during 14 years of surveillance by Croughs, P.D., Klaassen, C.H.W., van Rosmalen, J., Maghdid, D.M., Boers, S.A., Hays, J.P., Goessens, W.H.F.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Physiologically based pharmacokinetic model for humans orally exposed to chromium

    Physiologically based pharmacokinetic model for humans orally exposed to chromium by Kirman, C.R., Aylward, L.L., Suh, M., Harris, M.A., Thompson, C.M., Haws, L.C., Proctor, D.M., Lin, S.S., Parker, W., Hays, S.M.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  8. 8
    Phase I evaluation of lenvatinib and weekly paclitaxel in patients with recurrent endometrial, ovarian, fallopian tube, or primary peritoneal cancer

    Phase I evaluation of lenvatinib and weekly paclitaxel in patients with recurrent endometrial, ovarian, fallopian tube, or primary peritoneal cancer by Backes, F.J., Wei, L., Cohn, D.E., Salani, R., Hays, J.L., Fowler, J.M., Copeland, L.J., O'Malley, D.M.

    Published in Gynecologic oncology
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  9. 9
    Corrigendum to “Physiologically based pharmacokinetic model for rats and mice orally exposed to chromium” [Chem Biol Interact 2012;200:45–64]

    Corrigendum to “Physiologically based pharmacokinetic model for rats and mice orally exposed to chromium” [Chem Biol Interact 2012;200:45–64] by Kirman, C.R., Hays, S.M., Aylward, L.L., Suh, M., Harris, M.A., Thompson, C.M., Haws, L.C., Proctor, D.M.

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: